Literature DB >> 25429092

Ebola virus disease: roles and considerations for pharmacists.

Anthony J Guarascio1, Andrew C Faust2, Lyndsay Sheperd2, Lauren A O'Donnell3.   

Abstract

Ebola virus disease (EVD) poses significant clinical care implications for pharmacists. Emergency preparedness efforts should be undertaken to ensure vital response to EVD. Pharmacists should consider factors such as enhanced use of resources for front-line EVD patient care along with procurement of investigational medications. Appropriate and timely preparation, distribution, and administration of treatment for patients with EVD in the setting of substantial critical illness as well as infection control measures are essential. Aggressive supportive care and early, goal-directed therapy are cornerstones of therapy, whereas investigational treatments for EVD will likely play a larger, more well-defined role as future clinical trials are conducted.
© The Author(s) 2014.

Entities:  

Keywords:  antivirals; critical care; infectious diseases; personnel management; pharmaceutical care; sepsis; viral infections

Mesh:

Year:  2014        PMID: 25429092     DOI: 10.1177/1060028014561782

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

1.  Ebola virus disease: what canadian hospital pharmacists need to know.

Authors:  Tasha D Ramsey; Jennifer M Tung; Heather Balogh; April J Chan
Journal:  Can J Hosp Pharm       Date:  2015 Mar-Apr

2.  Correction.

Authors: 
Journal:  J Am Pharm Assoc (2003)       Date:  2020-11-01

3.  A Learner-led, Discussion-based Elective on Emerging Infectious Disease.

Authors:  Clinton Mathias
Journal:  Am J Pharm Educ       Date:  2015-08-25       Impact factor: 2.047

4.  The antiviral cytokine interferon-gamma restricts neural stem/progenitor cell proliferation through activation of STAT1 and modulation of retinoblastoma protein phosphorylation.

Authors:  Apurva Kulkarni; Taylor J Scully; Lauren A O'Donnell
Journal:  J Neurosci Res       Date:  2016-11-15       Impact factor: 4.164

5.  The burden of COVID-19 on pharmacists.

Authors:  Karlee Johnston; Claire L O'Reilly; Gabrielle Cooper; Imogen Mitchell
Journal:  J Am Pharm Assoc (2003)       Date:  2020-10-22

6.  Pharmacists self-perceived role competence in prevention and containment of COVID-19: A cross-sectional study.

Authors:  Suhaib Muflih; Sayer Al-Azzam; Lynn Lafferty; Reema Karasneh; Ola Soudah; Yousef Khader
Journal:  Ann Med Surg (Lond)       Date:  2021-03-26

7.  Ebola virus disease: How can African pharmacists respond to future outbreaks?

Authors:  Peter Bai James; Shazia Qasim Jamshed; Isha Patel
Journal:  Asian Pac J Trop Dis       Date:  2016-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.